Testosterone and Cardiovascular Disease
- PMID: 27014372
- PMCID: PMC4780522
- DOI: 10.2174/1874192401610010001
Testosterone and Cardiovascular Disease
Abstract
Cardiovascular disease [CVD] is a leading cause of mortality accounting for a global incidence of over 31%. Atherosclerosis is the primary pathophysiology underpinning most types of CVD. Historically, modifiable and non-modifiable risk factors were suggested to precipitate CVD. Recently, epidemiological studies have identified emerging risk factors including hypotestosteronaemia, which have been associated with CVD. Previously considered in the realms of reproductive biology, testosterone is now believed to play a critical role in the cardiovascular system in health and disease. The actions of testosterone as they relate to the cardiac vasculature and its implication in cardiovascular pathology is reviewed.
Keywords: Atherosclerosis; Cardiovascular disease; Hypogonadism; Testosterone; Vascular biology.
Figures
Similar articles
-
Role of Testosterone in the Treatment of Cardiovascular Disease.Eur Cardiol. 2017 Dec;12(2):83-87. doi: 10.15420/ecr.2017:21:1. Eur Cardiol. 2017. PMID: 30416559 Free PMC article. Review.
-
The effect of testosterone on cardiovascular disease: a critical review of the literature.Am J Mens Health. 2014 Nov;8(6):470-91. doi: 10.1177/1557988314522642. Epub 2014 Feb 20. Am J Mens Health. 2014. PMID: 24563500 Review.
-
Randomized controlled trials - mechanistic studies of testosterone and the cardiovascular system.Asian J Androl. 2018 Mar-Apr;20(2):120-130. doi: 10.4103/aja.aja_6_18. Asian J Androl. 2018. PMID: 29442075 Free PMC article. Review.
-
Testosterone and cardiovascular risk in men.Front Horm Res. 2014;43:1-20. doi: 10.1159/000360553. Epub 2014 Jun 10. Front Horm Res. 2014. PMID: 24943294 Review.
-
Testosterone, cardiovascular disease and the metabolic syndrome.Best Pract Res Clin Endocrinol Metab. 2011 Apr;25(2):337-53. doi: 10.1016/j.beem.2010.07.002. Best Pract Res Clin Endocrinol Metab. 2011. PMID: 21397202 Review.
Cited by
-
Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults.Hypertension. 2019 Dec;74(6):1266-1274. doi: 10.1161/HYPERTENSIONAHA.119.13080. Epub 2019 Oct 28. Hypertension. 2019. PMID: 31656099 Free PMC article. Review.
-
Advances in Cardiovascular Disease Lipid Research Can Provide Novel Insights Into Mycobacterial Pathogenesis.Front Cell Infect Microbiol. 2019 Apr 18;9:116. doi: 10.3389/fcimb.2019.00116. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 31058102 Free PMC article. Review.
-
A 3-year observation of testosterone deficiency in Chinese patients with chronic heart failure.Oncotarget. 2017 Aug 2;8(45):79835-79842. doi: 10.18632/oncotarget.19816. eCollection 2017 Oct 3. Oncotarget. 2017. PMID: 29108365 Free PMC article.
-
Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease in Men with Hypogonadism: A Real-Life Observational Registry Study Setting Comparing Treated and Untreated (Control) Groups.J Cardiovasc Pharmacol Ther. 2017 Sep;22(5):414-433. doi: 10.1177/1074248417691136. Epub 2017 Feb 9. J Cardiovasc Pharmacol Ther. 2017. PMID: 28421834 Free PMC article.
-
HC diet inhibited testosterone synthesis by activating endoplasmic reticulum stress in testicular Leydig cells.J Cell Mol Med. 2019 May;23(5):3140-3150. doi: 10.1111/jcmm.14143. Epub 2019 Mar 18. J Cell Mol Med. 2019. PMID: 30884106 Free PMC article.
References
-
- World Health Organization (WHO) Global status report on noncommunicable diseases 2014. 2014. pp. 1–302. Available at: http://www.who.int/nmh/publications/ncd-status-report-2014/en/
LinkOut - more resources
Full Text Sources
Other Literature Sources